Serabelisib
Showing 1 - 10 of 10
Advanced Solid Tumor, PIK3CA Mutation, PTEN Loss of Function Mutation Trial in United States (Serabelisib, Insulin Suppressing
Recruiting
- Advanced Solid Tumor
- +2 more
- Serabelisib
- Insulin Suppressing Diet
-
Birmingham, Alabama
- +9 more
May 25, 2022
Breast Cancer, Endometrial Cancer, Lung Cancer Trial (Serabelisib, Canagliflozin 300mg)
Unknown status
- Breast Cancer
- +4 more
- Serabelisib
- Canagliflozin 300mg
- (no location specified)
May 20, 2020
Advanced Solid Tumor Trial in Sioux Falls (paclitaxel, TAK-228, TAK-117)
Active, not recruiting
- Advanced Solid Tumor
- paclitaxel
- +2 more
-
Sioux Falls, South DakotaAvera Cancer Institute
Aug 24, 2021
Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Everolimus, MLN0128, MLN1117)
Completed
- Clear-cell Metastatic Renal Cell Carcinoma
- Everolimus
- +2 more
-
Los Angeles, California
- +35 more
Nov 18, 2021
Endometrial Tumors Trial in Worldwide (Paclitaxel, Sapanisertib, MLN1117)
Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma Trial in Spain, United States (MLN1117, TAK-659, Alisertib)
Terminated
- Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma
- MLN1117
- +4 more
-
Lake Success, New York
- +5 more
Aug 19, 2019
Advanced Nonhematologic Malignancies Trial in Spain, United Kingdom, United States (TAK-228, TAK-117)
Completed
- Advanced Nonhematologic Malignancies
-
Boston, Massachusetts
- +4 more
Oct 7, 2019
Tumor, Advanced or Metastatic Trial (TAK-117, Lansoprazole)
Completed
- Neoplasm, Advanced or Metastatic
- (no location specified)
Jul 21, 2017
NSCLC Trial in Canada, Netherlands, United States (Docetaxel, TAK-117)
Terminated
- Non-small Cell Lung Cancer
-
San Diego, California
- +10 more
Jan 12, 2018